MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of Pharmaceutical Development May 13, 2021
PsyBio Therapeutics Increases Intellectual Property Portfolio with Filing of Novel Genetic Optimization Pathways for… May 12, 2021
MINDCURE Shares Update on Strong Financial Position, Near Term Revenue Drivers and Timeline for iSTRYM’s Market… Apr 29, 2021